2021
DOI: 10.1016/j.compbiomed.2021.104802
|View full text |Cite
|
Sign up to set email alerts
|

In silico trials for treatment of acute ischemic stroke: Design and implementation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
25
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 22 publications
(27 citation statements)
references
References 77 publications
1
25
0
1
Order By: Relevance
“…As part of the INSIST project [ 64 ], we are developing computational models of AIS at multiple scales to aid in optimising AIS treatments and developing medical devices. The micro-scale models presented here and in previous works [ 37 , 40 ] can in future be coupled with organ-scale models of AIS [ 65 67 ] and play a key role in predicting the secondary tissue damage caused by microthrombi after an unsuccessful thrombectomy [ 68 70 ].…”
Section: Discussionmentioning
confidence: 99%
“…As part of the INSIST project [ 64 ], we are developing computational models of AIS at multiple scales to aid in optimising AIS treatments and developing medical devices. The micro-scale models presented here and in previous works [ 37 , 40 ] can in future be coupled with organ-scale models of AIS [ 65 67 ] and play a key role in predicting the secondary tissue damage caused by microthrombi after an unsuccessful thrombectomy [ 68 70 ].…”
Section: Discussionmentioning
confidence: 99%
“…The cerebral perfusion model is defined by a set of input parameters required to solve Equation (1) subject to the boundary condition Equations ( 4)- (6). The proposed computational perfusion model generation method integrates clinical data to set up simulations accordingly, as depicted in Figure 1.…”
Section: Computational Perfusion Model Generationmentioning
confidence: 99%
“…Thrombolysis [2] and thrombectomy [1] revolutionised stroke treatment but up to 66% of patients remain functionally dependent [3,4]. The IN Silico clinical trials for the treatment of acute Ischaemic STroke (INSIST) consortium [5,6] set out to improve existing stroke treatments based on computational models [7][8][9][10][11]. In AIS, perfusion shortage is the primary driver of infarct formation associated with irreversible brain tissue and function loss.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Miller et al [18] and Konduri et al [19] have previously published a framework for designing and implementing an IST for AIS. In this study, we present and integrate a novel surrogate model, based on logistic regression trained on outcomes from a finite-element model of thrombectomy, into our IST framework [18,19] and validate the model using the MR CLEAN trial [1,20] .…”
Section: Introductionmentioning
confidence: 99%